David Bird (born 1946 in London) is the world's most prolific bridge writer, with over one hundred books to his name. He is bridge correspondent for the Mail on ...
Dec 2012 to 2000 Senior Raw Material Buyer IIIAvid Technology Tewksbury, MA Sep 2006 to Dec 2012 Sr. Buyer / Planner / Inventory Control ManagerScholastic Book Fairs Marlborough, MA Mar 2005 to Sep 2006 Regional Inventory Control ManagerNew England Confectionary Company Revere, MA Jun 2003 to Mar 2005 Manager of Corporate Planning & Inventory Control
Education:
Cazenovia College 1997 Bachelor of Science in Interdisciplinary Social Sciences
Mollen Immunization Clinics, LLC Scottsdale, AZ 2008 to 2010 Customer Care Professional - Mollen Immunization Clinics, LLCBankers Life Glendale, AZ 2007 to 2008Tim's Buick Prescott, AZ 2003 to 2006 Accountant/Title ProcessorSo NH Medical Center Nashua, NH 2000 to 2003 Accounting ClerkGlendale Adventist Med Ctr Glendale, CA 1998 to 1999 Capitation Analyst - FinanceBusiness Office Glendale, CA 1996 to 1998 Accountant TechNMB (USA) Chatsworth, CA 1994 to 1995 Associate AccountantMSI Laboratories Burbank, CA 1992 to 1994 Medi-Cal SupervisorProgressive Orthopedic Mfg Sacramento, CA 1987 to 1992 A/R Supervisor
Us Patents
Therapeutic Compositions And Related Methods Of Use
William F. Kiesman - Wayland MA, US Mary Fure - East Hampstead NH, US John Kuczek - Lowell MA, US Aaron Deykin - Needham MA, US Barry Ticho - Cambridge MA, US David Bird - San Diego CA, US
International Classification:
A61K 31/52 A61P 9/00
US Classification:
51426324
Abstract:
Compositions and dosage forms including adenosine receptor antagonists such as 3-[4-(2,6-Dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-bicyclo[2.2.2]oct-1-yl]-propionic acid and methods of using the same are described herein.